George Yancopoulos (#2482)
I think we do discovery differently and better. And I think part of it is we've really learned how to brainstorm and think inventively in a group.
- $ 2 B
- Pharmaceuticals
- United States
- M
- 66 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
George Yancopoulos is the chief scientific officer of biotech firm Regeneron. He received his M.D. and Ph.D. from Columbia University and became a professor of biology by age 28. Regeneron was cofounded by now-billionaire Leonard Schleifer in 1988. Yancopoulos joined the next year. Yancopoulos led the invention of eleven FDA-approved drugs and a technology platform designed to invent more. Yancopoulos owns about 1% of Regeneron stock.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped George Yancopoulos’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking George Yancopoulos’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $1.6B
(May 4, 2026)
© Iconic Billionaires